These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 30763755)

  • 1. Recovery Trajectories and Long-Term Outcomes in Traumatic Brain Injury: A Secondary Analysis of the Phase 3 Citicoline Brain Injury Treatment Clinical Trial.
    Puffer RC; Yue JK; Mesley M; Billigen JB; Sharpless J; Fetzick AL; Puccio AM; Diaz-Arrastia R; Okonkwo DO
    World Neurosurg; 2019 May; 125():e909-e915. PubMed ID: 30763755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term outcome in traumatic brain injury patients with midline shift: a secondary analysis of the Phase 3 COBRIT clinical trial.
    Puffer RC; Yue JK; Mesley M; Billigen JB; Sharpless J; Fetzick AL; Puccio A; Diaz-Arrastia R; Okonkwo DO
    J Neurosurg; 2019 Aug; 131(2):596-603. PubMed ID: 30074459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of citicoline on functional and cognitive status among patients with traumatic brain injury: Citicoline Brain Injury Treatment Trial (COBRIT).
    Zafonte RD; Bagiella E; Ansel BM; Novack TA; Friedewald WT; Hesdorffer DC; Timmons SD; Jallo J; Eisenberg H; Hart T; Ricker JH; Diaz-Arrastia R; Merchant RE; Temkin NR; Melton S; Dikmen SS
    JAMA; 2012 Nov; 308(19):1993-2000. PubMed ID: 23168823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Divergent Six Month Functional Recovery Trajectories and Predictors after Traumatic Brain Injury: Novel Insights from the Citicoline Brain Injury Treatment Trial Study.
    Gardner RC; Cheng J; Ferguson AR; Boylan R; Boscardin J; Zafonte RD; Manley GT;
    J Neurotrauma; 2019 Sep; 36(17):2521-2532. PubMed ID: 30909795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The citicoline brain injury treatment (COBRIT) trial: design and methods.
    Zafonte R; Friedewald WT; Lee SM; Levin B; Diaz-Arrastia R; Ansel B; Eisenberg H; Timmons SD; Temkin N; Novack T; Ricker J; Merchant R; Jallo J
    J Neurotrauma; 2009 Dec; 26(12):2207-16. PubMed ID: 19803786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics and temporal profile of recovery in patients with favorable outcomes at 6 months after severe traumatic brain injury.
    Vedantam A; Robertson CS; Gopinath SP
    J Neurosurg; 2018 Jul; 129(1):234-240. PubMed ID: 28937323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional Outcomes Over the First Year After Moderate to Severe Traumatic Brain Injury in the Prospective, Longitudinal TRACK-TBI Study.
    McCrea MA; Giacino JT; Barber J; Temkin NR; Nelson LD; Levin HS; Dikmen S; Stein M; Bodien YG; Boase K; Taylor SR; Vassar M; Mukherjee P; Robertson C; Diaz-Arrastia R; Okonkwo DO; Markowitz AJ; Manley GT; ; Adeoye O; Badjatia N; Bullock MR; Chesnut R; Corrigan JD; Crawford K; Duhaime AC; Ellenbogen R; Feeser VR; Ferguson AR; Foreman B; Gardner R; Gaudette E; Goldman D; Gonzalez L; Gopinath S; Gullapalli R; Hemphill JC; Hotz G; Jain S; Keene CD; Korley FK; Kramer J; Kreitzer N; Lindsell C; Machamer J; Madden C; Martin A; McAllister T; Merchant R; Ngwenya LB; Noel F; Nolan A; Palacios E; Perl D; Puccio A; Rabinowitz M; Rosand J; Sander A; Satris G; Schnyer D; Seabury S; Sherer M; Toga A; Valadka A; Wang K; Yue JK; Yuh E; Zafonte R
    JAMA Neurol; 2021 Aug; 78(8):982-992. PubMed ID: 34228047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increases of Plasma Levels of Glial Fibrillary Acidic Protein, Tau, and Amyloid β up to 90 Days after Traumatic Brain Injury.
    Bogoslovsky T; Wilson D; Chen Y; Hanlon D; Gill J; Jeromin A; Song L; Moore C; Gong Y; Kenney K; Diaz-Arrastia R
    J Neurotrauma; 2017 Jan; 34(1):66-73. PubMed ID: 27312416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute Traumatic Coagulopathy Accompanying Isolated Traumatic Brain Injury is Associated with Worse Long-Term Functional and Cognitive Outcomes.
    Abdelmalik PA; Boorman DW; Tracy J; Jallo J; Rincon F
    Neurocrit Care; 2016 Jun; 24(3):361-70. PubMed ID: 26293923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Favorable Functional Recovery in Severe Traumatic Brain Injury Survivors beyond Six Months.
    Wilkins TE; Beers SR; Borrasso AJ; Brooks J; Mesley M; Puffer R; Chang YF; Okonkwo DO; Puccio AM
    J Neurotrauma; 2019 Nov; 36(22):3158-3163. PubMed ID: 31210093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variable neuroendocrine-immune dysfunction in individuals with unfavorable outcome after severe traumatic brain injury.
    Santarsieri M; Kumar RG; Kochanek PM; Berga S; Wagner AK
    Brain Behav Immun; 2015 Mar; 45():15-27. PubMed ID: 25218898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Citicoline in severe traumatic brain injury: indications for improved outcome : A retrospective matched pair analysis from 14 Austrian trauma centers.
    Trimmel H; Majdan M; Wodak A; Herzer G; Csomor D; Brazinova A
    Wien Klin Wochenschr; 2018 Jan; 130(1-2):37-44. PubMed ID: 28752349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unsupervised Machine Learning Reveals Novel Traumatic Brain Injury Patient Phenotypes with Distinct Acute Injury Profiles and Long-Term Outcomes.
    Folweiler KA; Sandsmark DK; Diaz-Arrastia R; Cohen AS; Masino AJ
    J Neurotrauma; 2020 Jun; 37(12):1431-1444. PubMed ID: 32008422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Citicoline on the Barthel Index: Severe and moderate brain injury.
    Mahmoodkhani M; Aminmansour B; Shafiei M; Hasas M; Tehrani DS
    Indian J Pharmacol; 2023; 55(4):223-228. PubMed ID: 37737074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is aura around citicoline fading? A systemic review.
    Agarwal S; Patel BM
    Indian J Pharmacol; 2017; 49(1):4-9. PubMed ID: 28458415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of cerebrolysin on functional recovery in patients with severe disability after traumatic brain injury: A historical cohort study.
    Khalili H; Niakan A; Ghaffarpasand F
    Clin Neurol Neurosurg; 2017 Jan; 152():34-38. PubMed ID: 27871029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of hospital-acquired pneumonia on long-term recovery and hospital resource utilization following moderate to severe traumatic brain injury.
    Kumar RG; Kesinger MR; Juengst SB; Brooks MM; Fabio A; Dams-O'Connor K; Pugh MJ; Sperry JL; Wagner AK
    J Trauma Acute Care Surg; 2020 Apr; 88(4):491-500. PubMed ID: 31804412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Injury-to-Admission Delay Beyond 4 Hours Is Associated with Worsening Outcomes for Traumatic Brain Injury in Cambodia.
    Barthélemy EJ; Spaggiari R; Corley J; Lepard JR; Staffa SJ; Iv V; Servadei F; Park KB
    World Neurosurg; 2019 Jun; 126():e232-e240. PubMed ID: 30825623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurological outcome scale for traumatic brain injury: III. Criterion-related validity and sensitivity to change in the NABIS hypothermia-II clinical trial.
    McCauley SR; Wilde EA; Moretti P; Macleod MC; Pedroza C; Drever P; Fourwinds S; Frisby ML; Beers SR; Scott JN; Hunter JV; Traipe E; Valadka AB; Okonkwo DO; Zygun DA; Puccio AM; Clifton GL
    J Neurotrauma; 2013 Sep; 30(17):1506-11. PubMed ID: 23617608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early trajectory of psychiatric symptoms after traumatic brain injury: relationship to patient and injury characteristics.
    Hart T; Benn EK; Bagiella E; Arenth P; Dikmen S; Hesdorffer DC; Novack TA; Ricker JH; Zafonte R
    J Neurotrauma; 2014 Apr; 31(7):610-7. PubMed ID: 24237113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.